1. Home
  2. ETON vs GNSS Comparison

ETON vs GNSS Comparison

Compare ETON & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • GNSS
  • Stock Information
  • Founded
  • ETON 2017
  • GNSS 1992
  • Country
  • ETON United States
  • GNSS United States
  • Employees
  • ETON N/A
  • GNSS N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • GNSS Consumer Electronics/Appliances
  • Sector
  • ETON Health Care
  • GNSS Consumer Staples
  • Exchange
  • ETON Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • ETON 388.3M
  • GNSS 78.1M
  • IPO Year
  • ETON 2018
  • GNSS N/A
  • Fundamental
  • Price
  • ETON $14.85
  • GNSS $1.96
  • Analyst Decision
  • ETON Strong Buy
  • GNSS Strong Buy
  • Analyst Count
  • ETON 3
  • GNSS 3
  • Target Price
  • ETON $29.67
  • GNSS $5.33
  • AVG Volume (30 Days)
  • ETON 621.3K
  • GNSS 131.5K
  • Earning Date
  • ETON 08-07-2025
  • GNSS 08-05-2025
  • Dividend Yield
  • ETON N/A
  • GNSS N/A
  • EPS Growth
  • ETON N/A
  • GNSS N/A
  • EPS
  • ETON N/A
  • GNSS N/A
  • Revenue
  • ETON $48,327,000.00
  • GNSS $27,780,000.00
  • Revenue This Year
  • ETON $103.21
  • GNSS $91.14
  • Revenue Next Year
  • ETON $51.34
  • GNSS $75.44
  • P/E Ratio
  • ETON N/A
  • GNSS N/A
  • Revenue Growth
  • ETON 40.88
  • GNSS N/A
  • 52 Week Low
  • ETON $3.25
  • GNSS $1.46
  • 52 Week High
  • ETON $21.48
  • GNSS $4.04
  • Technical
  • Relative Strength Index (RSI)
  • ETON 54.31
  • GNSS 70.78
  • Support Level
  • ETON $13.78
  • GNSS $1.48
  • Resistance Level
  • ETON $16.27
  • GNSS $1.85
  • Average True Range (ATR)
  • ETON 0.83
  • GNSS 0.10
  • MACD
  • ETON 0.32
  • GNSS 0.05
  • Stochastic Oscillator
  • ETON 77.67
  • GNSS 98.11

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: